VeriMompolyvinylacetamide est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
Related ingredients
Frequently asked questions
- polyvinylacetamide est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS or CIR reproductive safety opinion located, and no peer‑reviewed evidence of reproductive or teratogenic effects of poly(N‑vinylacetamide) or its use in cosmetics was found. Regulatory/INCI sources treat this as a polymer (polymer concerns typically focus on residual monomer). Sources searched showed INCI entries and substance pages but no harmonised flags or safety assessments for reproductive endpoints. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- polyvinylacetamide est-il sûr pendant l'allaitement ?
- No data found showing transfer to breast milk or adverse effects during lactation for polyvinylacetamide. No authoritative safety assessment (CIR/SCCS/harmonised CLP) raising reproductive/lactation concerns was identified; therefore default scoring is 0. Potential concern would relate to residual monomer (N‑vinylacetamide) if present, but no data on levels or breast‑milk transfer were located. ([cosmileeurope.eu](https://cosmileeurope.eu/inci/detail/12550/polyvinylacetamide/?utm_source=openai))
- polyvinylacetamide est-il sûr pour la peau de bébé ?
- No evidence of developmental or infant‑specific hazard was found. For exposure (e) infants have a less mature skin barrier and higher surface‑area‑to‑weight ratio; polymers like poly(N‑vinylacetamide) are generally of low dermal absorption, so adult exposure is negligible (e=0) but infant exposure is increased to e=1 to reflect higher potential per‑weight exposure and possibility of measurable absorption if small amounts of low‑molecular‑weight species (residual monomer) are present. There is no infant‑specific toxicology showing increased hazard. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Poly%28N-vinylacetamide%29?utm_source=openai))
- Comment VeriMom évalue-t-il polyvinylacetamide ?
- VeriMom évalue polyvinylacetamide à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à polyvinylacetamide pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à polyvinylacetamide basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.